Read more about the article Belay Diagnostics names Stanford neuro-oncologist Seema Nagpal, MD, its first chief medical officer

Belay Diagnostics names Stanford neuro-oncologist Seema Nagpal, MD, its first chief medical officer

  • Post author:
  • Post published:
  • Post category:Sales & Growth

Nagpal's experience treating patients with CNS cancers will help shape Belay's clinical strategy and expand the use of CSF liquid biopsy testingCHICAGO, Nov. 10, 2026 /PRNewswire/ -- Belay Diagnostics today announced that Seema Nagpal, MD, a practicing Stanford…

Continue ReadingBelay Diagnostics names Stanford neuro-oncologist Seema Nagpal, MD, its first chief medical officer
Read more about the article TriNetX Launches Human-Validated Fact Extraction from Clinical Notes Data Researchers Can Trust

TriNetX Launches Human-Validated Fact Extraction from Clinical Notes Data Researchers Can Trust

New NLP-extracted clinical facts are confidence-scored, tested against human-annotated notes, and linked to structured EHR data for the same de-identified patients CAMBRIDGE, Mass., Nov. 10, 2026 /PRNewswire/ -- As artificial intelligence (AI) makes extracting information from clinical notes easier…

Continue ReadingTriNetX Launches Human-Validated Fact Extraction from Clinical Notes Data Researchers Can Trust
Read more about the article Lundbeck raises full-year guidance as 9M revenue grows +13% CER (+11% CER underlying) and adjusted EBITDA +19% CER, led by Vyepti®

Lundbeck raises full-year guidance as 9M revenue grows +13% CER (+11% CER underlying) and adjusted EBITDA +19% CER, led by Vyepti®

  • Post author:
  • Post published:
  • Post category:Business

VALBY, Denmark, Nov. 10, 2026 /PRNewswire/ -- Key highlightsLundbeck's total revenue grew by +13% CER[1] (+9% DKK) to DKK 20,191 million in the first nine months of 2026, with all regions contributing to the growth. The performance reflected…

Continue ReadingLundbeck raises full-year guidance as 9M revenue grows +13% CER (+11% CER underlying) and adjusted EBITDA +19% CER, led by Vyepti®